Nika Pharmaceuticals, Inc (NIKA) EPS (Basic) (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly EPS (Basic) came in at -$0.0 in Q3 2023, down 35.26% YoY from -$0.0 in Q3 2022, and up 63.52% on a QoQ basis from -$0.0 in Q2 2023.
Nika Pharmaceuticals, Inc (NIKA) EPS (Basic) (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of EPS (Basic) data on file, last reported at -$0.0 in Q3 2023.
- Quarterly EPS (Basic) fell 35.26% year-over-year to -$0.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was -$0.0 (up 98.5% YoY) and the FY2022 annual result came in at -$0.0, down 294.66% from the prior year.
- EPS (Basic) improved to -$0.0 in Q3 2023, from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.0 in Q1 2022 to a low of -$0.0 in Q2 2022.
- A 3-year average of -$0.0 and a median of -$0.0 in 2022 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 209.77% in 2022, down 2001.45% in 2022.
- Tracing NIKA's EPS (Basic) over 3 years: stood at -$0.0 in 2021, then soared by 98.95% to -$0.0 in 2022, then jumped by 44.31% to -$0.0 in 2023.
- The last three EPS (Basic) figures came in at -$0.0 (Q3 2023), -$0.0 (Q2 2023), and -$0.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |